These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3078198

  • 21. Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent.
    MacCarthy P, Isaac P, Frost G, Freeman A, Stokes G.
    Clin Exp Pharmacol Physiol; 1978; 5(2):187-90. PubMed ID: 348364
    [Abstract] [Full Text] [Related]

  • 22. Non-invasive monitoring of ambulatory blood pressure and its variability in elderly hypertensive patients: effect of guanfacine.
    Dupont AG, Vanderniepen P, Six RO.
    Bibl Cardiol; 1987; (42):161-7. PubMed ID: 3307757
    [No Abstract] [Full Text] [Related]

  • 23. [Guanfacine in the treatment of arterial hypertension. Apropos of 471 cases in a hospital milieu].
    Carette B.
    Ann Cardiol Angeiol (Paris); 1984; 33(2):123-6. PubMed ID: 6143529
    [No Abstract] [Full Text] [Related]

  • 24. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Dvorák I, Podrouzková B, Kocourková J, Kubesová H, Spác J, Nĕmcová H, Blaha M.
    Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
    [Abstract] [Full Text] [Related]

  • 25. [Guanfacine in primary arterial hypertension: a long-term open clinical study].
    Román O, Valenzuela MA, Salazar R.
    Rev Med Chil; 1982 Dec; 110(12):1179-84. PubMed ID: 6764015
    [No Abstract] [Full Text] [Related]

  • 26. [Use of estulic in patients with arterial hypertension].
    Kukes VG, Spasskiĭ AV, Alkhazov AI, Rudakov AG, Zisel'man SB.
    Sov Med; 1985 Dec; (12):57-61. PubMed ID: 3913006
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical experience with guanfacine in long-term treatment of hypertension.
    Jerie P.
    Br J Clin Pharmacol; 1980 Dec; 10 Suppl 1(Suppl 1):37S-47S. PubMed ID: 6994777
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [A new antihypertensive agent used in a clinical setting].
    Wetzels E, Raschig A, Kaiser HJ.
    Med Klin; 1980 Sep 12; 75(19):688-92. PubMed ID: 7001207
    [Abstract] [Full Text] [Related]

  • 38. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
    Manhem P, Hökfelt B.
    Br J Clin Pharmacol; 1980 Sep 12; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
    [Abstract] [Full Text] [Related]

  • 39. [Clinical pharmacology of the newer antihypertensive agents].
    Rahn KH.
    Internist (Berl); 1983 Mar 12; 24(3):128-34. PubMed ID: 6347939
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.